Patents by Inventor Catrin Berger

Catrin Berger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20180194846
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 12, 2018
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20180134791
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: July 23, 2015
    Publication date: May 17, 2018
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20160031993
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: July 23, 2015
    Publication date: February 4, 2016
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20130344091
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: August 29, 2013
    Publication date: December 26, 2013
    Applicant: Novartis AG
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • Compositions and methods for increasing muscle growth
    Patent number: 8551482
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Grant
    Filed: May 31, 2012
    Date of Patent: October 8, 2013
    Assignee: Novartis AG
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stephanie Urlinger
  • Compositions and methods for increasing muscle growth
    Patent number: 8388968
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Grant
    Filed: April 26, 2010
    Date of Patent: March 5, 2013
    Assignee: Novartis AG
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stefanie Urlinger
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20120237521
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: May 31, 2012
    Publication date: September 20, 2012
    Applicant: NOVARTIS AG
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle Trifilieff, Stefanie Urlinger
  • Compositions and methods of use for antibodies of c-Met
    Patent number: 8101727
    Abstract: Antibodies and fragments that bind to the protein target c-Met, particularly to epitopes located in the c-Met extracellular domain, are provided, as are methods of use of the antibodies and kits, for treating an unwanted cell, in particular, a cell associated with a c-Met-related condition such as a cancer, a metastasis, or an inflammatory condition.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: January 24, 2012
    Assignee: Novartis AG
    Inventors: David Raymond Stover, Josef Prassler, Catrin Berger, Bodo Brocks
  • COMPOSITIONS AND METHODS FOR INCREASING MUSCLE GROWTH
    Publication number: 20100272734
    Abstract: This disclosure is in the field of anti-Activin receptor IIB (ActRIIB) antibodies. In particular, it relates to the use of said antibodies for treating muscle disorders, such as muscle wasting due to disease or disuse.
    Type: Application
    Filed: April 26, 2010
    Publication date: October 28, 2010
    Inventors: Catrin Berger, Tanja Herrmann, Chris Lu, Kelly-Ann Sheppard, Estelle TRIFILIEFF, Stefanie Urlinger
  • Compositions and Methods of Use for Antibodies of c-Met
    Publication number: 20090175860
    Abstract: Antibodies and fragments that bind to the protein target c-Met, particularly to epitopes located in the c-Met extracellular domain, are provided, as are methods of use of the antibodies and kits, for treating an unwanted cell, in particular, a cell associated with a c-Met-related condition such as a cancer, a metastasis, or an inflammatory condition.
    Type: Application
    Filed: March 29, 2007
    Publication date: July 9, 2009
    Inventors: David Raymond Stover, Josef Prassler, Catrin Berger, Bodo Brocks